FDA Taps Flatiron for 5-Year Real-World Data Collaboration

HIT Consultant September 6, 2023
Syed Hamza Sohail

What You Should Know:

• Flatiron Health today announced its renewed collaboration with the Oncology Center of Excellence (OCE) of FDA to jointly develop and implement specific research projects to advance the use of Real World Data (RWD) and explore the potential strengths and limitations of using Real World Evidence (RWE) for regulatory purposes.
• The partnership will specifically evaluate RWD study designs and analytic methods through the collaborative development of priority, clinically meaningful research questions regarding care, treatment, and outcomes of patients with cancer.

New Collaboration to Broaden Horizon for Clinically Meaningful Medical Research

“Flatiron is honored to further our collaboration with FDA,” said Javier Jimenez, Chief Medical Officer, Flatiron Health. “Flatiron and FDA will collaborate to...

Today's Sponsors

Today's Sponsor